SCHEMBL5757698

SCHEMBL5757698

CN(C)CCCn1nc(C2=C(c3cn(Cc4cccc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 16/20 0.73
PRKCB P05771 15/20 0.73
GSK3B P49841 13/20 0.73
PRKCG P05129 12/20 0.73
PRKCD Q05655 9/20 0.73
KCNH2 Q12809 6/20 0.66
PRKCZ Q05513 4/20 0.66
PRKCH P24723 3/20 0.64
PRKCQ Q04759 3/20 0.64
PRKACA P17612 3/20 0.57
PRKACG P22612 3/20 0.57
PRKACB P22694 3/20 0.57
PIM1 P11309 2/20 0.57
PRKCE Q02156 3/20 0.53
CCNB2 O95067 3/20 0.53
CDK1 P06493 3/20 0.53
CCNB1 P14635 3/20 0.53
CCNB3 Q8WWL7 3/20 0.53
MEN1 O00255 1/20 0.53
PRKD3 O94806 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755061 0.87 PRKCA (0.67) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL5754176 0.87 PRKCA (0.75) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL5752512 0.86 PRKCA (0.67) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL5756314 0.85 PRKCA (0.73) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL5755677 0.85 PRKCA (0.80) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL3779530 0.84 PRKCA (1.00) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL3775416 0.84 GSK3B (0.79) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL3777376 0.83 GSK3B (0.75) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL3784374 0.82 PRKCA (0.76) PRKCAPRKCBGSK3BPRKCGPRKCD
SCHEMBL5759233 0.81 PRKCA (0.65) PRKCAPRKCBGSK3BPRKCGPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362047-B1 INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS ORTHO MCNEIL PHARM INC (US) 2006-05-17 EP disclosed